Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

HHS Deputy Secretary Azar to depart

Executive Summary

Alex Azar leaves his HHS post Feb. 3 to return to the private sector. Before serving as deputy secretary, Azar was HHS general counsel from 2001 to 2005. He had been involved in implementing the Medicare prescription drug benefit and was on the HHS importation task force...

You may also be interested in...



Lilly leadership changes

Alex Azar II will join Lilly as senior VP-corporate affairs and communications, the company announces May 4. Previously, Azar served as HHS Deputy Secretary for two years ending in February (1"The Pink Sheet" Jan. 22, 2007, In Brief). The company also announces that Ann Nobles will be chief compliance officer. Nobles has been with Lilly for over 16 years, most recently serving as VP-Corporate Affairs...

Political Oversight Of Agency Guidances, Rules Slated For House Hearing

Two House subcommittees are planning a joint hearing on amended 1Executive Order 12866, which institutionalizes the review of federal agency regulations and guidance documents by presidential appointees rather than career agency staff

'Touchless Plants' To Virtually Trained Workforces - Indian Cos Share Digitalization Tips

Despite AI and digital analytics playing an increasing role in pharma, the industry lags others globally, a recent event heard. Meanwhile, top Indian players including Sun Pharma, Cipla and others shared what is driving their initiatives, ranging from a 'touchless factory' to virtual training and lessons learned along the way.

UsernamePublicRestriction

Register

PS143249

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel